Curso virtual sobre reducción de daños y terapia de sustitución de opiáceos en prisiones

Noticias

Curso virtual sobre reducción de daños y terapia de sustitución de opiáceos en prisiones

29 enero 2014

Entre fines de marzo y mediados de abril de 2014, se organizarán dos módulos virtuales sobre reducción de daños y terapia de sustitución de opiáceos en prisiones. El plazo para inscribirse finaliza el 9 de marzo.

Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

Two e-learning modules on “Harm reduction in prison” and “Opioid substitution treatment in prison” have been launched in the framework of the CARE project. The modules will run between the end of March and mid-May 2014.

All information about the training, its content and structure and required timeframe are available here.

The harm reduction course is primarily addressed to professionals in health and social services working either within the prison or outside. They may be employed as civil servants within state agencies or in NGOs. The opiate substitution therapy in prisons training wants to support prison doctors, contracted doctors, prison health care workers, prison administration, NGOs and others in delivering or supporting substitution treatment. Preference will be given to participants from European Union and neighbouring countries.

Colleagues interested in taking part in the training, should fill in the attached registration form and send it back to Ms. Cinzia Brentari before the 9 March.

The training will be delivered in English, so the only expectation from trainees is a sufficient knowledge of English, as well as a specific interest and possibly some expertise on drugs, infections and the prison setting.

Please advertise this opportunity widely among your contacts and colleagues at the prison administration and other health and social care structures in your area and through your website and newsletters.

For any further information please contact Ms. Cinzia Brentari.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.